Biomaterials – materials sciences Journal Guide for Researchers

Why Researchers Choose Biomaterials for High-Impact Publications

Biomaterials stands as a cornerstone in the field of materials sciences, offering a premier platform for groundbreaking research in biomedical applications. Established in 1980 by Elsevier, this journal has evolved into one of the most influential outlets for scientists exploring the intersection of materials engineering and biology. With a focus on novel materials that interact with living systems, Biomaterials publishes peer-reviewed articles that advance understanding in areas like tissue regeneration, implantable devices, and nanomedicine. Its rigorous editorial process ensures only the highest quality work reaches publication, making it a sought-after choice for researchers aiming to disseminate impactful findings.

The journal's scope encompasses a wide array of disciplines, from biomaterials design and synthesis to their clinical translation. Researchers value Biomaterials for its ability to bridge fundamental science with practical applications, often leading to citations in multidisciplinary fields. The impact factor of 15.3, as reported in the 2022 Journal Citation Reports by Clarivate, underscores its prestige, placing it among the top tier in materials sciences. This metric reflects not just citation volume but the relevance and innovation of published work, attracting submissions from global leaders in academia and industry.

Publishing in Biomaterials offers significant value beyond metrics. It provides visibility through Elsevier's extensive distribution network, including ScienceDirect, which boasts millions of users worldwide. Authors benefit from open access options that amplify reach, while the journal's adherence to ethical standards ensures credibility. For early-career researchers, a publication here can propel career trajectories, opening doors to funding and collaborations. The submission process, though competitive, rewards meticulous preparation and novel contributions.

To explore how Biomaterials fits into your research strategy, consider reviewing academic job opportunities in materials sciences. Browse materials science faculty positions to connect your work with potential career moves.

Overview & History

Biomaterials was launched in 1980 by Elsevier, a leading global publisher based in the Netherlands. Initially focused on the science of materials used in medical devices, the journal quickly gained traction for its forward-thinking approach to biocompatibility and biofunctionality. Over the decades, it has chronicled pivotal advancements, from early polymer implants to modern regenerative medicine techniques. Today, it remains a vital resource, publishing over 300 articles annually that shape the biomaterials landscape.

The journal's evolution mirrors the field's growth, incorporating emerging topics like 3D bioprinting and smart materials. Its commitment to interdisciplinary research has fostered collaborations across engineering, chemistry, and biology, solidifying its role as a historical benchmark in materials sciences.

Scope and Disciplines Covered

Biomaterials covers the design, synthesis, and application of materials intended for interaction with biological systems. Key areas include tissue engineering, drug delivery systems, and biomimetic materials. The journal emphasizes experimental and theoretical studies that advance clinical outcomes.

DisciplineDescription
Materials SciencesCore focus on material properties and synthesis for biomedical use.
Biomedical EngineeringApplications in implants, scaffolds, and diagnostic tools.
ChemistrySurface modifications and chemical interactions with cells.
BiologyBiocompatibility testing and in vivo studies.
MedicineTranslational research toward therapeutic devices.

Key Journal Metrics

Biomaterials boasts robust metrics that highlight its influence in materials sciences. The 2022 impact factor of 15.3 positions it as a high-impact venue, with an h-index exceeding 300, indicating sustained citation influence.

MetricValueSource
Impact Factor (2022)15.3Clarivate JCR
5-Year Impact Factor14.8Clarivate JCR
CiteScore24.5Scopus
Acceptance RateApproximately 20%Publisher data
Time to First Decision4 weeksElsevier

Indexing and Abstracting

Biomaterials is indexed in major databases, ensuring broad discoverability. It appears in PubMed/MEDLINE, Scopus, Web of Science, and Embase, facilitating access for researchers in materials sciences and beyond. This indexing supports high visibility and compliance with funding mandates.

Publication Model and Fees

Biomaterials operates a hybrid model, allowing authors to choose traditional subscription access or open access. For open access, the article processing charge (APC) is €3,770 (approximately $4,000 USD), covering publication costs and ensuring immediate availability. Subscription access incurs no fees for authors, with articles accessible via institutional licenses.

Elsevier offers waivers for corresponding authors from low-income countries, promoting global equity in materials sciences research dissemination.

Submission Process and Guidelines

Submissions to Biomaterials are handled through Elsevier's Editorial Manager system. Authors must prepare manuscripts per the journal's guidelines, including double-spaced text, high-resolution figures, and ethical statements. Original research, reviews, and perspectives are welcome, with a emphasis on novelty in biomaterials applications.

The process involves initial screening, peer review by 2-3 experts, and revisions. Average time from submission to publication is 6 months. Detailed guidelines are available on the official site.

Editorial Board Highlights

The editorial board of Biomaterials comprises distinguished experts in materials sciences. Editor-in-Chief David Williams, a pioneer in biocompatibility, leads a team from institutions like Imperial College London and the University of Twente. Notable members include specialists in nanotechnology and regenerative medicine, ensuring diverse, high-caliber oversight.

Why Publish in Biomaterials?

Publishing in Biomaterials elevates research profiles due to its prestige and reach. The journal's impact factor attracts citations, while its scope aligns with cutting-edge materials sciences trends. Authors gain from rapid dissemination and networking opportunities at Elsevier events.

For career growth, consider resources like professor ratings. Rate My Professor to connect with mentors in biomaterials.

Comparison with Similar Journals

Biomaterials compares favorably with peers in materials sciences, offering superior metrics and broader scope.

JournalImpact FactorPublisherFocus
Biomaterials15.3ElsevierBiomedical materials
Advanced Materials32.1WileyGeneral materials
Acta Biomaterialia9.7ElsevierBiomaterials mechanics
Journal of Biomedical Materials Research4.9WileyClinical applications
Biomaterials Science6.6RSCSoft matter biomaterials

Researcher Tips for Successful Submission

To succeed in submitting to Biomaterials, emphasize innovation and clinical relevance in your abstract. Ensure robust methodology and high-quality data visualization. Engage with recent publications to position your work contextually. Proofread for clarity, and highlight interdisciplinary aspects to appeal to the journal's audience.

Additionally, stay informed on academic timelines. Check the academic calendar for conference deadlines that align with submission cycles. Other useful links include biomedical engineering jobs, materials science PhD opportunities, tenure-track positions, postdoc fellowships in biomaterials, faculty recruitment in materials sciences, research grants for biomedical materials, and career advice on publishing tips.

Frequently Asked Questions about Biomaterials

πŸ“ˆWhat is the current impact factor of Biomaterials?

The 2022 impact factor for Biomaterials is 15.3, according to Clarivate Journal Citation Reports, making it a top choice in materials sciences. For career impact, explore materials science faculty positions.

πŸ”What is the acceptance rate for submissions to Biomaterials?

Biomaterials has an acceptance rate of approximately 20%, reflecting its selective process. This prestige aids career growth; check Rate My Professor for insights from peers.

πŸ’°What is the APC or publication policy for Biomaterials?

As a hybrid journal, Biomaterials charges an APC of €3,770 for open access articles. Subscription model is free for authors. Review policies on the academic calendar for planning.

⏱️How long is the average review time for Biomaterials?

The average time to first decision is 4 weeks, with full publication around 6 months. This efficiency supports timely career moves; see postdoc fellowships in biomaterials.

πŸ“Where do I submit my manuscript to Biomaterials?

Submissions are via Elsevier's Editorial Manager portal on the journal site. Prepare per guidelines for success. For related opportunities, visit biomedical engineering positions.

πŸ“šWhat indexing services cover Biomaterials?

Biomaterials is indexed in PubMed, Scopus, Web of Science, and Embase, ensuring wide reach. This boosts visibility; explore research grants for biomedical materials.

πŸ‘¨β€πŸ’ΌWho is the Editor-in-Chief of Biomaterials?

David Williams serves as Editor-in-Chief, with expertise in biocompatibility. His leadership enhances journal quality. Network via faculty recruitment in materials sciences.

πŸš€What career value does publishing in Biomaterials provide?

A publication in Biomaterials significantly boosts academic profiles, aiding tenure and funding. Leverage this with tenure-track positions in the field.

βš–οΈHow does Biomaterials compare to peer journals?

Biomaterials outperforms many peers with its 15.3 impact factor versus Acta Biomaterialia's 9.7. For comparisons, see career advice on publishing tips.
Β